Back

Inflammation is associated with high disease burden and adverse outcomes in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a real-world evidence study

28 August 2026 (15:00 - 15:10)
Organised by: Logo
Congress Presentation Part of: Coronary microvascular dysfunction and ANOCA: sex differences, mechanisms, and clinical impact Inflammation and Immunity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Sa'ar Minha

Yitzhak Shamir Medical Center, Beer Yakov (Israel)

5 More presentations in this session

Presentation thumbnail
A targeted and safe strategy for post-infarction anti-inflammatory therapy: cardiac-restricted NLRP3 inhibition via a biomimetic nanocarrier
Doctor Z. Zhou (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Sex-specific physiological landscapes in ANOCA: the interplay between epicardial resistance and coronary vasomotor dysfunction—insights from the J-CMD Registry
Doctor H. Ueno (Tsuchiura, JP)
Abstract Slides Video
Presentation thumbnail
Implications of elevated resting microvascular resistance: results from MICRO-SNAPE
Doctor O. Velollari (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Long-term angina-related healthcare utilization in women with ANOCA and impaired coronary flow velocity reserve
Miss L. Rytoft (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Systemic progression of atherosclerosis after STEMI: a prospective cohort analysis
Doctor D. Pavluk (Innsbruck, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary microvascular dysfunction and ANOCA: sex differences, mechanisms, and clinical impact
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 15:00 CET
You may be interested in
thumbnail
Congress Session
The heart and the kidney
28 August 2023
thumbnail
Congress Session
Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?
27 August 2022
thumbnail
Congress Presentation
Systemic inflammation and risk of death in patients with atherosclerotic cardiovascular disease and chronic kidney disease.
30 August 2024
thumbnail
Congress Presentation
Residual inflammation, cholesterol risks and rates of major cardiovascular events in routinely cared patients with atherosclerotic cardiovascular disease
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources